Annotated Medicine and Device Lists

Metronidazole

Gel 0.75% Injection 500 mg in 100-mL vial Injection 500 mg Injection 5 mg/mL Oral liquid 200 mg (as benzoate)/5 mL Oral liquid 250 mg (benzoate)/5 mL Oral liquid 125 mg (benzoate)/5 mL Suppository 500 mg Suppository 1 g Suspension 250 mg/5 mL Suspension 125 mg/5 mL Suspension 150-250 mg/5 mL Tablet 200 mg to 500 mg Tablet 500 mg Tablet 250 mg Vaginal tablet 500 mg

This medicine is present in:

List	Section	Observation
Cuba	6.1.1.1 Fármacos activos contra Ameba, Giardia, Trichomonas	No observations
Cuba	13.2 Antiinfecciosos	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.5.1. Antiamoebic and antigiardiasis medicines	Others observations: Therapeutic alternatives: tinidazole
Cuba	6.1.1.1 Fármacos activos contra Ameba, Giardia, Trichomonas	No observations
WHO Model List of Essential Medicines (2021)	6.2.1. Access group antibiotics	Others observations: FIRST CHOICE − C. difficile infection − Complicated intraabdominal infections (mild to moderate) − Complicated intrabdominal infections (severe) − Necrotizing fasciitis − Surgical prophylaxis − Trichomoniasis SECOND CHOICE − Complicated intraabdominal infections (mild to moderate)

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
Peru	6.2.2.7 Miscellaneous	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	4.0 Anti-Infectious	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.5.1. Antiamoebic and antigiardiasis medicines	Others observations: Therapeutic alternatives: tinidazole
WHO Model List of Essential Medicines (2021)	6.2.1. Access group antibiotics	Others observations: FIRST CHOICE − C. difficile infection − Complicated intraabdominal infections (mild to moderate) − Complicated intrabdominal infections (severe) − Necrotizing fasciitis − Surgical prophylaxis − Trichomoniasis SECOND CHOICE − Complicated intraabdominal infections (mild to moderate)

This medicine is present in:

List	Section	Observation
Peru	6.2.2.7 Miscellaneous	No observations
Peru	6.5.1 Amebicides, Giardicides, Tricomonicides	No observations
Colombia	03.4.1 Antiamoebas	No observations

This medicine is present in:

List	Section	Observation
Colombia	03.4.1 Antiamoebas	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	10.10 Vaginal Therapies	No observations
WHO Model List of Essential Medicines (2021)	6.2.1. Access group antibiotics	Others observations: FIRST CHOICE − C. difficile infection − Complicated intraabdominal infections (mild to moderate) − Complicated intrabdominal infections (severe) − Necrotizing fasciitis − Surgical prophylaxis − Trichomoniasis SECOND CHOICE − Complicated intraabdominal infections (mild to moderate)

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.2.1. Access group antibiotics	Others observations: FIRST CHOICE − C. difficile infection − Complicated intraabdominal infections (mild to moderate) − Complicated intrabdominal infections (severe) − Necrotizing fasciitis − Surgical prophylaxis − Trichomoniasis SECOND CHOICE − Complicated intraabdominal infections (mild to moderate)

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.5.1. Antiamoebic and antigiardiasis medicines	Others observations: Therapeutic alternatives: tinidazole
WHO Model List of Essential Medicines (2021)	6.2.1. Access group antibiotics	Others observations: FIRST CHOICE − C. difficile infection − Complicated intraabdominal infections (mild to moderate) − Complicated intrabdominal infections (severe) − Necrotizing fasciitis − Surgical prophylaxis − Trichomoniasis SECOND CHOICE − Complicated intraabdominal infections (mild to moderate)

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.5.1. Antiamoebic and antigiardiasis medicines	No observations
Bolivia	LINAME 2011 - 2013	No observations
Peru	6.2.2.7 Miscellaneous	No observations
Peru	6.5.1 Amebicides, Giardicides, Tricomonicides	No observations
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	03.4.1 Antiamoebas	No observations

This medicine is present in:

List	Section	Observation
Chile	Essential and Prioritized Medications	No observations
Colombia	03.4.1 Antiamoebas	No observations
Cuba	6.1.1.1 Fármacos activos contra Ameba, Giardia, Trichomonas	No observations
WHO Model List of Essential Medicines (2021)	6.5.1. Antiamoebic and antigiardiasis medicines	No observations

This medicine is present in:

List	Section	Observation
Cuba	6.1.1.1 Fármacos activos contra Ameba, Giardia, Trichomonas	No observations

Information Resources: Metronidazole

Para el tratamiento de la tricomoniasis vaginal, ¿es más eficaz el tinidazol oral que el metronidazol oral?
Tricomoniasis vaginal